Furthermore, the activation of pattern recognition receptors, such as Toll-like receptor 9 (TLR9), by endogenous ligands in SLE exacerbates inflammation and accelerates atherosclerosis progression [7,8]. Here, TLR9 is linked to systemic lupus erythematosus.